Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

440 ARTíCULOS , VIENDO DEL 376 AL 390

PUBMED

Prefrontal executive function associated coupling relates to Huntington's disease stage.

Unschuld PG, Liu X, Shanahan M, Margolis RL, Bassett SS, Brandt J, Schretlen DJ, Redgrave GW, Hua J, Hock C, Reading SA, van Zijl PC, Pekar JJ, Ross CA.

Cortex. 2013 Nov-Dec;49(10):2661-73. doi: 10.1016/j.cortex.2013.05.015.

0

0

0

PUBMED

S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.

Haun F, Nakamura T, Shiu AD, Cho DH, Tsunemi T, Holland EA, La Spada AR, Lipton SA.

Antioxid Redox Signal. 2013 Oct 10;19(11):1173-84. doi: 10.1089/ars.2012.4928.

0

0

0

PUBMED

Acetylcholinesterase inhibitors in cognitive impairment in Huntington's disease: A brief review.

Vattakatuchery JJ, Kurien R.

World J Psychiatry. 2013 Sep 22;3(3):62-4. doi: 10.5498/wjp.v3.i3.62.

0

0

0

PUBMED

Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease.

Jin J, Albertz J, Guo Z, Peng Q, Rudow G, Troncoso JC, Ross CA, Duan W.

J Neurochem. 2013 May;125(3):410-9. doi: 10.1111/jnc.12190.

0

0

0

PUBMED

A systematic review of the intergenerational aspects and the diverse genetic profiles of Huntington's disease.

Agostinho LA, Dos Santos SR, Alvarenga RM, Paiva CL.

Genet Mol Res. 2013 Jun 13;12(2):1974-81. doi: 10.4238/2013.June.13.6. Review.

0

0

0

PUBMED

Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset.

Ramos EM, Latourelle JC, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Gellera C, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ,

Neurogenetics. 2013 Nov;14(3-4):173-9. doi: 10.1007/s10048-013-0364-y.

0

0

0

PUBMED

Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability.

Cisbani G, Freeman TB, Soulet D, Saint-Pierre M, Gagnon D, Parent M, Hauser RA, Barker RA, Cicchetti F.

Brain. 2013 Feb;136(Pt 2):433-43. doi: 10.1093/brain/aws359.

0

0

0

PUBMED

Managing juvenile Huntington's disease.

Quarrell OW, Nance MA, Nopoulos P, Paulsen JS, Smith JA, Squitieri F.

Neurodegener Dis Manag. 2013 Jun 1;3(3). doi: 10.2217/nmt.13.18.

0

0

0

PUBMED

Spinocerebellar Ataxia (SCA) type 2 presenting with chorea.

Bhalsing KS, Sowmya V, Netravathi M, Jain S, Pal PK.

Parkinsonism Relat Disord. 2013 Dec;19(12):1171-2. doi: 10.1016/j.parkreldis.2013.08.004. No abstract available.

0

0

0

PUBMED

A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin.

Damiano M, Diguet E, Malgorn C, D'Aurelio M, Galvan L, Petit F, Benhaim L, Guillermier M, Houitte D, Dufour N, Hantraye P, Canals JM, Alberch J, Delzescaux T, Déglon N, Beal MF, Brouillet E.

Hum Mol Genet. 2013 Oct 1;22(19):3869-82. doi: 10.1093/hmg/ddt242.

0

0

0

PUBMED

JAK/STAT Signalling in Huntington's Disease Immune Cells.

Träger U, Magnusson A, Lahiri Swales N, Wild E, North J, Lowdell M, Björkqvist M.

PLoS Curr. 2013 Dec 13;5. pii: ecurrents.hd.5791c897b5c3bebeed93b1d1da0c0648. doi: 10.1371/currents.hd.5791c897b5c3bebeed93b1d1da0c0648.

0

0

0

PUBMED

Doing the right thing for one's children: deciding whether to take the genetic test for Huntington's disease as a moral dilemma.

Smith JA, Stephenson M, Jacobs C, Quarrell O.

Clin Genet. 2013 May;83(5):417-21. doi: 10.1111/cge.12124.

0

0

0

PUBMED

Lithium treatment in patients with Huntington disease and suicidal behavior.

Raja M, Soleti F, Bentivoglio AR.

J Clin Psychopharmacol. 2013 Dec;33(6):819-21. doi: 10.1097/JCP.0b013e31829c9748. No abstract available.

0

0

0

PUBMED

Why psychometrics is important - a response to: Aubeeluck, Buchanan & Stupple (2013) Journal of Huntington's Disease 2(4) 453-454.

Hagell P, Smith S.

J Huntingtons Dis. 2013;2(4):455-7. doi: 10.3233/JHD-139009. No abstract available.

0

0

0

PUBMED

Association between caffeine intake and age at onset in Huntington's disease.

Simonin C, Duru C, Salleron J, Hincker P, Charles P, Delval A, Youssov K, Burnouf S, Azulay JP, Verny C, Scherer C, Tranchant C, Goizet C, Debruxelles S, Defebvre L, Sablonnière B, Romon-Rousseaux M,

Neurobiol Dis. 2013 Oct;58:179-82. doi: 10.1016/j.nbd.2013.05.013.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy